Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study
暂无分享,去创建一个
[1] Michael Hauptmann,et al. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M Colonna,et al. Cancer incidence and mortality in France over the period 1980-2005. , 2008, Revue d'epidemiologie et de sante publique.
[3] J. Coebergh,et al. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Soloway,et al. Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk? , 2007, European urology.
[5] Elisabeth G. E. de Vries,et al. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands , 2007, Breast Cancer Research and Treatment.
[6] H. Brenner,et al. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] G. Launoy,et al. Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). , 2007, European journal of cancer.
[8] Matthew J Hayat,et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. , 2007, The oncologist.
[9] K. Hemminki,et al. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology , 2007, Breast Cancer Research and Treatment.
[10] M. Goodman,et al. Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975–2001 , 2006, Cancer.
[11] J. Olsen,et al. Risk of second cancer among women with breast cancer , 2006, International journal of cancer.
[12] A. Neugut,et al. Incidences and Trends of Second Cancers in Female Breast Cancer Patients: A Fixed Inception Cohort-based Analysis (United States) , 2006, Cancer Causes & Control.
[13] A. Lesur,et al. Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l‘ovaire (mise à jour 2004) , 2004 .
[14] H. Sobol,et al. [Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)]. , 2004, Bulletin du cancer.
[15] J. Fraumeni,et al. Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer. , 2004, Journal of the National Cancer Institute.
[16] E. Kliewer,et al. Incidence of Second Primary Breast Cancer Among Women with a First Primary in Manitoba, Canada , 2001, Breast Cancer Research and Treatment.
[17] C. Rubino,et al. Increased risk of second cancers following breast cancer: Role of the initial treatment , 2000, Breast Cancer Research and Treatment.
[18] J. Hopper,et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.
[19] C. la Vecchia,et al. Cancer risk in women with previous breast cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[20] C. Lewis,et al. The risk of subsequent primary cancers after colorectal cancer in southeast England , 2002, Gut.
[21] E. Buiatti,et al. Multiple primary cancer incidence in Italy. , 2001, European journal of cancer.
[22] Jeffrey S. Morris,et al. Effect of age on risk of second primary colorectal cancer. , 2001, Journal of the National Cancer Institute.
[23] K. Hemminki,et al. Second primary neoplasms in 633,964 cancer patients in Sweden, 1958–1996 , 2001, International journal of cancer.
[24] K. Hemminki,et al. Second primary cancers after sporadic and familial colorectal cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[25] C. Lewis,et al. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England , 2001, British Journal of Cancer.
[26] K. Hemminki,et al. Risk factors and age‐incidence relationships for contralateral breast cancer , 2000, International journal of cancer.
[27] H. Hollema,et al. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer , 2000, The Lancet.
[28] C. Bonithon-Kopp,et al. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] I. Ellis,et al. Clinical and histological predictors of contralateral breast cancer. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[30] F Levi,et al. Second primary tumors after prostate carcinoma , 1999, Cancer.
[31] M. McCredie,et al. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[32] R. Sankila,et al. Risk of subsequent malignant neoplasms among 470,000 cancer patients in Finland, 1953‐1991 , 1995, International journal of cancer.
[33] L. Ries,et al. Leukemia following chemotherapy for breast cancer. , 1990, Cancer research.